Income Tax Expense (Benefit) of Zivo Bioscience, Inc. from 31 Mar 2022 to 31 Mar 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Zivo Bioscience, Inc. quarterly Income Tax Expense (Benefit) in USD history and change rate from 31 Mar 2022 to 31 Mar 2024.
Zivo Bioscience, Inc. Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $0.
Source SEC data: View on sec.gov

Income Tax Expense (Benefit), Quarterly (USD)

Zivo Bioscience, Inc. Quarterly Income Tax Expense (Benefit) (USD)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2024		$0	$0		01 Jan 2024	31 Mar 2024	10-Q	13 May 2024	2024	Q1
Q1 2023		$0	$0		01 Jan 2023	31 Mar 2023	10-Q	13 May 2024	2024	Q1
Q1 2022		$0			01 Jan 2022	31 Mar 2022	10-Q	10 May 2023	2023	Q1

* An asterisk sign (*) next to the value indicates that the value is likely invalid.